Integration and scale up of care package for patients with lymphoedema in Ethiopia. The project aligns with drug development, diagnostic development and complex interventions platforms of CDT-Africa. The project is a collaborative undertaking of CDT-Africa and the Brighton and Sussex Medical School, UK. The 3 main focus areas include: (1) Development of anti-infective and antiscabies topical products (which will evolve into skin care product development); (2) Diagnostic development focusing on techniques for diagnosing lymphedema at an early stage; (3) Complex intervention, which aims to integrate and scale up a holistic package of community-level care, including physical and psychosocial care, into government-run health services for patients with lymphedema, specifically podoconiosis, lymphatic filariasis and leprosy, in selected districts in Ethiopia. The complex intervention study has three phases, and the work has begun in partnership with the Amhara regional health bureau and the Awi zone in Ethiopia. The UK National Institute of Health Research (NIHR) funds the project for a total amount of £805,052. CDT-Africa’s Centre Head is the Principal Investigator of the project. The overall lead of the project, Prof Gail Davey, leads the partnership of CDT-Africa with the BSMS and University of Sussex.